Phage Therapy Center
Bacteriophage Therapy for Patients Across the Globe
HOME F.A.Q. CONTACT US LOGIN
Language Translation

About Our Company
About Us, What We Do
Our History
Our Mission
Our Management
Phage Therapy
Phage Therapy Center Clinics
Become A Patient
News
Web Links
Patient
Physicians
 

John Curtin, Centers for Disease Control and Prevention
The Use of Bacteriophage for the Reduction of Catheter-Associated Infections.
105th General Meeting of the American Society for Microbiology June 5-9

D. Jikia, N. Chkhaidze*, E. Imedashvili*, I. Mgaloblishvili, G. Tsitlanadze, R. Katsarava, J. Glenn Morris, Jr, Alexander Sulakvelidze
The use of a novel biodegradable preparation capable of the sustained release of bacteriophages and ciprofloxacin, in the complex treatment of multidrug-resistant Staphylococcus aureus-infected local radiation injuries caused by exposure to Sr90
Clinical and Experimental Dermatology, January 2005

Mathur MD, Vidhani S, Mehndiratta PL.
Bacteriophage Therapy: an Alternative to Conventional Antibiotics
J Assoc Physicians India. 2003 Jun

Weber-Dabrowska B, Mulczyk M, Gorski A.
Bacteriophages as an efficient therapy for antibiotic-resistant septicemia in man
Transplant Proc. 2003 Jun

N Chanishvili, T Chanishvili, M Tediashvili, PA Barrow
Phages and their application against drug-resistant bacteria
Journal of Chemical Technology and Biotechnology, 2001

Sulakvelidze A, Morris JG Jr.
Bacteriophages as Therapeutic Agents
Ann Med. 2001 Nov

Alexander Sulakvelidze, Zemphira Alavidze, and J. Glenn Morris Jr.
Bacteriophage Therapy
Antimicrobial Agents and Chemotherapy, March 2001

Lakhno VM, Bordunovskii VN.
Use of Bacteriophage Therapy in Surgical Practice
Vestn Khir Im I I Grek. 2001

Weber-Dabrowska B, Mulczyk M, Gorski A
Bacteriophage Therapy of Bacterial Infections: an Update of Our Institute's Experience
Archivum Immunologiae et Therapiae Experimentalis, 2000

Shabalova, I. A., N. I. Karpanov, V. N. Krylov, T. O. Sharibjanova, and V. Z. Akhverdijan.
Pseudomonas aeruginosa bacteriophage in treatment of P. aeruginosa infection in cystic fibrosis patients,
Proceedings of IX International Cystic Fibrosis Congress. International Cystic Fibrosis Association, Zurich, Switzerland.1995.

Perepanova, T. S., O. S. Darbeeva, G. A. Kotliarova, E. M. Kondrat'eva, L. M. Maiskaia, V. F. Malysheva, F. A. Baiguzina, and N. V. Grishkova. 
The efficacy of bacteriophage preparations in treating inflammatory urologic diseases.
Urol. Nefrol. 5:14-17. 1995

Kwarcinski W, Lazarkiewicz B, Weber-Dabrowska B, Rudnicki J, Kaminski K
Bacteriophage therapy in the treatment of recurrent subphrenic and subhepatic abscess with jejunal fistula after stomach resection
Pol Tyg Lek. 1994 Jun

Pavlenishvili, I., and T. Tsertsvadze.
Bacteriophagotherapy and enterosorbtion in treatment of sepsis of newborns caused by gram-negative bacteria.
Pren. Neon. Infect. 11:104 1993.

Kaczkowski, H., B. Weber-Dabrowska, M. Dabrowski, Z. Zdrojewicz, and F. Cwioro.
Use of bacteriophages in the treatment of chronic bacterial diseases.
Wiad. Lek. 43:136-141 1990.

Kochetkova VA, Mamontov AS, Moskovtseva RL, Erastova EI, Trofimov EI
Phagotherapy of Postoperative Suppurative-inflammatory Complications In patients with Neoplasms
Sov Med. 1989

Kucharewicz-Krukowska A, Slopek S.
Immunogenic effect of bacteriophage in patients subjected to phage therapy
Arch Immunol Ther Exp (Warsz). 1987;

Weber-Dabrowska B, Dabrowski M, Slopek S.
Studies on bacteriophage penetration in patients subjected to phage therapy
Arch Immunol Ther Exp (Warsz). 1987

Slopek S, Weber-Dabrowska B, Dabrowski M, Kucharewicz-Krukowska A.
Results of bacteriophage treatment of suppurative bacterial infections in the years 1981-1986.
Arch Immunol Ther Exp (Warsz). 1987

Slopek S, Weber-Dabrowska B, Dabrowski M, Kucharewicz-Krukowska A.
Results of bacteriophage treatment of suppurative bacterial infections in the years 1981-1986.  II. Detailed evaluation of the results.
Arch Immunol Ther Exp (Warsz). 1987

Timoshchuk II, Natsiashvili EIa, Chanishvili TG, Meladze GD.
Experience with bacteriophage therapy in nonspecific suppurative lung diseases
Grudn Khir. 1985 Mar-Apr

Slopek S, Kucharewicz-Krukowska A, Weber-Dabrowska B, Dabrowski M.
Results of Bacteriophage Treatment of Suppurative Bacterial Infections. VI. Analysis of Treatment of Suppurative Staphylococcal infections
Arch Immunol Ther Exp (Warsz). 1985

Slopek S, Kucharewicz-Krukowska A, Weber-Dabrowska B, Dabrowski M.
Results of Bacteriophage Treatment of Suppurative Bacterial Infections. V. Evaluation of the Results Obtained in Children.
Arch Immunol Ther Exp (Warsz). 1985

Slopek S, Kucharewicz-Krukowska A, Weber-Dabrowska B, Dabrowski M.
Results of Bacteriophage Treatment of Suppurative Bacterial Infections. IV. Evaluation of the Results Obtained in 370 Cases.
Arch Immunol Ther Exp (Warsz). 1985

Slopek S, Durlakowa I, Weber-Dabrowska B, Dabrowski M
Results of Bacteriophage Treatment of Suppurative Bacterial Infections. III. Detailed Evaluation of the Results Obtained in Further 150 Cases.
Arch Immunol Ther Exp (Warsz). 1984

Anpilov, L. I., and A. A. Prokudin.
Preventive effectiveness of dried polyvalent Shigella bacteriophage in organized collective groups.
Voenno-Med. Zh. 5:39-40. 1984

Slopek S, Durlakowa I, Weber-Dabrowska B, Kucharewicz-Krukowska A
Results of bacteriophage treatment of suppurative bacterial infections. I. General evaluation of the results
Arch Immunol Ther Exp (Warsz). 1983

Peremitina, L. D., E. A. Berillo, and A. G. Khvoles
Experience in the therapeutic use of bacteriophage preparations in suppurative surgical infections.
Zh. Mikrobiol. Epidemiol. Immunobiol. 9:109-110 1981

Ioseliani, G. D., G. D. Meladze, N. S. Chkhetiia, M. G. Mebuke, and N. I. Kiknadze. .
Use of bacteriophage and antibiotics for prevention of acute postoperative empyema in chronic suppurative lung diseases.
Grudn. Khir. 6:63-67 1980

Lang G, Kehr P, Mathevon H, Clavert JM, Sejourne P, Pointu J.
Bacteriophage therapy of septic complications of orthopaedic surgery
Rev Chir Orthop Reparatrice Appar Mot. 1979 Jan-Feb

Zhukov-Verezhnikov, N. N., L. D. Peremitina, E. A. Berillo, V. P. Komissarov, V. M. Bardymov, A. G. Khvoles, and L. B. Ugryumov.
A study of the therapeutic effect of bacteriophage agents in a complex treatment of suppurative surgical diseases.
Sov. Med. 12:64-66, 1978.

Kostrzewski J, Mulczyk M, Slopek S.
Prevention of dysentery infections in human collectivities by means of polyvalent bacteriophages S. flexneri and S. sonnei
Przegl Epidemiol. 28(4):483-507. Polish 1974;

Mulczyk M, Slopek S.
Use of a new phage preparation in prophylaxis and treatment of shigellosis.
Acta Microbiol Acad Sci Hung. 1974

Vartapetov AIa.
Materials on the study of bacteriophage therapy of deep forms of staphyloderma
Vestn Dermatol Venerol. 1974 Nov; Russian

Proskurov, V. A.
Use of staphylococcal bacteriophage for therapeutic and preventive purposes.
Zh. Mikrobiol. Epidemiol. Immunobiol. 2:104-107 1970.

Peitzman SJ.
Felix d'Herelle and bacteriophage therapy
Trans Stud Coll Physicians Phila. 1969 Oct

Babalova, E. G., K. T. Katsitadze, L. A. Sakvarelidze, N. S. Imnaishvili, T. G. Sharashidze, V. A. Badashvili, G. P. Kiknadze, A. N. Meipariani, N. D. Gendzekhadze, E. V. Machavariani, K. L. Gogoberidze, E. I. Gozalov, and N. G. Dekanosidze.
Preventive value of dried dysentery bacteriophage.
Zh. Mikrobiol. Epidemiol. Immunobiol. 2:143-145. 1968.

Wittig HJ, Raffetto JF, Bason R.
Bacteriophage therapy in infective childhood asthma
JAMA. 1966 May

WITOSZKA M, STRUMILLO B.
BACTERIOPHAGE THERAPY OF INFECTED SURGICAL WOUNDS
Pol Tyg Lek. 1963 Mar

CLAEYS R.
Study on a product with antibiotic action: antibiophagin
Acta Otorhinolaryngol Belg. 1962

Desranleau, J.M.
Progress in the Treatment of Typhoid Fever with Vi Phages
Candian Journal of Public Health, Novia Scotia, Halifax, Cananda, 1949

Knouf, E. G., Ward, W. E., Reichle, P. A., Bower, A. G. and Hamilton, P. M.
Treatment of typhoid fever with type-specific bacteriophage.
J Am Med Assn 132: 134-136, 1946

Morton, H. E. and Engely, F. B.
Dysentery Bacteriophage: Review of the Literature on its Prophylactic and Therapeutic Uses in Man and in Experimental Infections in Animals.
J Am Med Assoc 127: 584-591, 1945

Dubos, R., Straus, J. H. and Pierce, C.
The multiplication of bacteriophage in vivo and its protective effect against an experimental infection with Shigella dysenteriae.
J Exp Med, 1943

Pokrovskaya, M. P., L. C. Kaganova, M. A. Morosenko, A. G. Bulgakova, and E. E. Skatsenko.
Treatment of wounds with bacteriophages
2nd ed. State Publishing House "Medgiz,", Moscow, USSR.1942.

Ward J. MacNeal, Frances C. Frisbee, Margaret McRae
Staphylococcemia 1931-1940. FIVE HUNDRED PATIENTS
Dept of Bacteriology, NY Postgraduate Medical School and Hospital, Columbia University, NY

Case Histories
William McGann [Staphylococcus sepsis]
Coney Island Hospital, NY 1935
Frank Corso [Staphylococcus sepsis]
Columbus Hospital, New York City, NY 1938